The crystal structure of diethyl 1,4-dihydro-2,6-dimethyl-4-(3-cyanophenyl)-3,5-pyridinedicarboxylate, C20H22N2O4

被引:0
|
作者
Zhang, Li [1 ]
Yu, Hai-yan [1 ]
Wang, Ying-lei [1 ]
Sun, Ke-nan [1 ]
Tian, Ye [1 ]
机构
[1] Nanyang Inst Technol, Sch Biol & Chem Engn, Nanyang 473004, Peoples R China
关键词
2326059; CALCIUM-CHANNEL ANTAGONISTS;
D O I
10.1515/ncrs-2023-0521
中图分类号
O7 [晶体学];
学科分类号
0702 ; 070205 ; 0703 ; 080501 ;
摘要
C20H22N2O4, monoclinic, P2(1)/n (no. 14), a = 11.4033(15) & Aring;, b = 14.2998(16) & Aring;, c = 11.6486(16) & Aring;, beta = 91.197(8)degrees, V = 1899.1(4) & Aring;(3), Z = 4, R-gt(F) = 0.0513, wR(ref)(F-2) = 0.1542, T = 296.2 K.
引用
收藏
页码:269 / 271
页数:3
相关论文
共 50 条
  • [1] STRUCTURE OF METHYL 2-(NITROOXY)ETHYL 1,4-DIHYDRO-2,6-DIMETHYL-4-(3-NITROPHENYL)-3,5-PYRIDINEDICARBOXYLATE
    OGAWA, T
    MATSUMOTO, K
    YOKOO, C
    HATAYAMA, K
    KITAMURA, K
    ACTA CRYSTALLOGRAPHICA SECTION C-CRYSTAL STRUCTURE COMMUNICATIONS, 1993, 49 : 993 - 996
  • [2] DIETHYL 2,6-DIMETHYL-4-PHENYL-1,4-DIHYDRO-3,5-PYRIDINEDICARBOXYLATE
    HEMPEL, A
    GUPTA, MP
    ACTA CRYSTALLOGRAPHICA SECTION B-STRUCTURAL SCIENCE, 1978, 34 (DEC): : 3815 - 3817
  • [3] STRUCTURE OF DIETHYL 1,4-DIHYDRO-2,4,6-TRIMETHYL-3,5-PYRIDINEDICARBOXYLATE, C14H21NO4
    FORTIER, S
    FRASER, ME
    MOORE, NJ
    PARK, YS
    WHITNEY, RA
    MARKS, GS
    ACTA CRYSTALLOGRAPHICA SECTION C-CRYSTAL STRUCTURE COMMUNICATIONS, 1985, 41 (MAR) : 411 - 413
  • [4] BIOTRANSFORMATION OF 1,4-DIHYDRO-2,6-DIMETHYL-4-(2-TRIFLUOROMETHYLPHENYL)-3,5-PYRIDINEDICARBOXYLIC ACID DIETHYL ESTER
    PARKER, SE
    WEINSTOCK, J
    JOURNAL OF MEDICINAL CHEMISTRY, 1973, 16 (01) : 34 - 37
  • [5] Mechanistic aspects of the electrochemical oxidation of diethyl 1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylate on a glassy carbon electrode
    Montoya, MR
    Galvin, RM
    Mellado, MR
    Mozo, JD
    ELECTROANALYSIS, 1999, 11 (16) : 1241 - 1244
  • [6] PHARMACOLOGY OF A NEW CALCIUM ANTAGONISTIC COMPOUND, ISOBUTYL METHYL 1,4-DIHYDRO-2,6-DIMETHYL-4-(2-NITROPHENYL)-3,5-PYRIDINEDICARBOXYLATE (NISOLDIPINE, BAY-K-5552)
    KAZDA, S
    GARTHOFF, B
    MEYER, H
    SCHLOSSMANN, K
    STOEPEL, K
    TOWART, R
    VATER, W
    WEHINGER, E
    ARZNEIMITTEL-FORSCHUNG/DRUG RESEARCH, 1980, 30-2 (12): : 2144 - 2162
  • [7] METABOLISM OF ANTIHYPERTENSIVE AGENT 1,4-DIHYDRO-2,6-DIMETHYL-4-(2-TRIFLUOROMETHYLPHENYL)-3,5-PYRIDINEDICARBOXYLIC ACID DIETHYL ESTER
    WALKENSTEIN, SS
    INTOCCIA, AP
    FLANAGAN, TL
    HWANG, B
    FLINT, D
    WEINSTOCK, J
    VILLANI, AJ
    BLACKBURN, D
    GREEN, H
    JOURNAL OF PHARMACEUTICAL SCIENCES, 1973, 62 (04) : 580 - 584
  • [8] SYNTHESIS AND BIOLOGICAL-ACTIVITIES OF OPTICAL ISOMERS OF 2-(4-DIPHENYLMETHYL-1-PIPERAZINYL)ETHYL METHYL 1,4-DIHYDRO-2,6-DIMETHYL-4-(3-NITROPHENYL)-3,5-PYRIDINEDICARBOXYLATE (MANIDIPINE) DIHYDROCHLORIDE
    KAJINO, M
    WADA, Y
    NAGAI, Y
    NAGAOKA, A
    MEGURO, K
    CHEMICAL & PHARMACEUTICAL BULLETIN, 1989, 37 (08) : 2225 - 2228
  • [9] SYNTHESIS AND PHARMACOLOGICAL EFFECTS OF OPTICALLY-ACTIVE 2-[4-(4-BENZHYDRYL-1-PIPERAZINYL)PHENYL]ETHYL METHYL 1,4-DIHYDRO-2,6-DIMETHYL-4-(3-NITROPHENYL)-3,5-PYRIDINEDICARBOXYLATE HYDROCHLORIDE
    ASHIMORI, A
    UCHIDA, T
    OHTAKI, Y
    TANAKA, M
    OHE, K
    FUKAYA, C
    WATANABE, M
    KAGITANI, M
    YOKOYAMA, K
    CHEMICAL & PHARMACEUTICAL BULLETIN, 1991, 39 (01) : 108 - 111
  • [10] Evaluation of photostability of solid-state dimethyl 1,4-dihydro-2,6-dimethyl-4-(2-nitro-phenyl)-3,5-pyridinedicarboxylate by using Fourier-transformed reflection-absorption infrared spectroscopy
    Teraoka, R
    Otsuka, M
    Matsuda, Y
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 1999, 184 (01) : 35 - 43